title: Seroreversion in children infected with HIV type 1 who are treated in the first months of life is not a rare event.
authors.forename: Marc
authors.initials: M
authors.lastname: Hainaut
authors.forename: Cécile Alexandra
authors.initials: CA
authors.lastname: Peltier
authors.forename: Tessa
authors.initials: T
authors.lastname: Goetghebuer
authors.forename: Dimitri
authors.initials: D
authors.lastname: Van der Linden
authors.forename: Denise
authors.initials: D
authors.lastname: Marissens
authors.forename: Georges
authors.initials: G
authors.lastname: Zissis
authors.forename: Jack
authors.initials: J
authors.lastname: Levy
mesh_terms: D000367:Age Factors; D023241:Antiretroviral Therapy, Highly Active; D015658:HIV Infections / Q000188:drug therapy / Q000276:immunology*; D006679:HIV Seropositivity / Q000276:immunology*; D015497:HIV-1; D006801:Humans; D007223:Infant; D007231:Infant, Newborn